Literature DB >> 5597

Pharmacological characterization of adrenergic receptors of a rabbit cerebral artery in vitro.

S P Duckles, J A Bevan.   

Abstract

In the light of controversy over the functional significance of the abundant sympathetic innervation of large cerebral blood vessels, an in vitro analysis of the adrenergic receptors mediating contractile effects in the rabbit basilar artery was undertaken. Beta adrenergic stimulation had no effect, and agents that block norepinephrine (NE) uptake did not alter contractile responses to l-NE. The l-NE dose-response curve could be resolved into two components S-shaped curves: the first had an ED50 OF 10(-5) M and reached a plateau at 10(-4) M; the second component continued above 10(-3) M without reaching a plateau. Phenylephrine and epinephrine dose-response curves were also biphasic; d-NE responses corresponded to the second phase of the l-NE curve. Relative potencies for the two components were different. For the first component, these were 1:0.23:0.18:0.03 for l-NE, epinephrine, phenylephrine and d-NE, respectively; relative potencies for the second component of the curve were 1:1:0.11:0.23. Phentolamine dissociation constants were analyzed separately for each component. The value for low l-NE concentrations was 5 X 10 (-8) M and, for higher concentrations, it was 3 X 10(-6) . The insensitivity of the alpha adrenergic receptor and the poor responsiveness of the muscle to its activation with agonist concentrations below 10(-4) M can probably account for the small contractile responses to nerve stimulation of large pial arteries in spite of their abundant innervation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5597

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Pharmacological characterization of postjunctional alpha-adrenoceptors in cerebral arteries from the sheep.

Authors:  A J Gaw; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

2.  Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonist, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations.

Authors:  C R Cain; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Influence of the endothelium and alpha-adrenoreceptor antagonists on responses to noradrenaline in the rabbit basilar artery.

Authors:  C J Garland
Journal:  J Physiol       Date:  1989-11       Impact factor: 5.182

4.  Membrane properties of rabbit basilar arteries and their responses to transmural stimulation.

Authors:  A Surprenant; T O Neild; M E Holman
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

5.  Noradrenaline receptors on the rat basilar artery.

Authors:  G D Hirst; T O Neild; G D Silverberg
Journal:  J Physiol       Date:  1982-07       Impact factor: 5.182

6.  Characterisation of smooth muscle alpha-adrenoceptors and of responses to electrical stimulation in the cat isolated perfused middle cerebral artery.

Authors:  I C Medgett; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

7.  Electrophysiological analysis of the nature of adrenoceptors in the rat basilar artery during development.

Authors:  N G Byrne; G D Hirst; W A Large
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

8.  Pharmacological characterization of the alpha adrenoceptors of the dog basilar artery.

Authors:  Y Sakakibara; M Fujiwara; I Muramatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

9.  Membrane properties and excitatory neuromuscular transmission in the smooth muscle of dog cerebral arteries.

Authors:  S Fujiwara; T Itoh; H Suzuki
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

10.  Functional activity of the noradrenergic innervation of large cerebral arteries.

Authors:  S P Duckles
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.